These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The opioid receptor binding of dezocine, morphine, fentanyl, butorphanol and nalbuphine. Chen JC; Smith ER; Cahill M; Cohen R; Fishman JB Life Sci; 1993; 52(4):389-96. PubMed ID: 8093631 [TBL] [Abstract][Full Text] [Related]
5. Opioid efficacy in a C6 glioma cell line stably expressing the human kappa opioid receptor. Remmers AE; Clark MJ; Mansour A; Akil H; Woods JH; Medzihradsky F J Pharmacol Exp Ther; 1999 Feb; 288(2):827-33. PubMed ID: 9918595 [TBL] [Abstract][Full Text] [Related]
6. Discriminative stimulus effects of the mixed-opioid agonist/antagonist dezocine: cross-substitution by mu and delta opioid agonists. Picker MJ J Pharmacol Exp Ther; 1997 Dec; 283(3):1009-17. PubMed ID: 9399970 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological Characterization of Dezocine, a Potent Analgesic Acting as a κ Partial Agonist and μ Partial Agonist. Wang YH; Chai JR; Xu XJ; Ye RF; Zan GY; Liu GY; Long JD; Ma Y; Huang X; Xiao ZC; Dong H; Wang YJ Sci Rep; 2018 Sep; 8(1):14087. PubMed ID: 30237513 [TBL] [Abstract][Full Text] [Related]
8. Three-choice discrimination in pigeons is based on relative efficacy differences among opioids. Walker EA; Picker MJ; Dykstra LA Psychopharmacology (Berl); 2001 Jun; 155(4):389-96. PubMed ID: 11441428 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety. Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975 [TBL] [Abstract][Full Text] [Related]
10. Characterization of kappa opioid receptor mediated, dynorphin-stimulated [35S]GTPγS binding in mouse striatum for the evaluation of selective KOR ligands in an endogenous setting. Zhou L; Stahl EL; Lovell KM; Frankowski KJ; Prisinzano TE; Aubé J; Bohn LM Neuropharmacology; 2015 Dec; 99():131-41. PubMed ID: 26160155 [TBL] [Abstract][Full Text] [Related]
11. The in vitro pharmacology of the peripherally restricted opioid receptor antagonists, alvimopan, ADL 08-0011 and methylnaltrexone. Beattie DT; Cheruvu M; Mai N; O'Keefe M; Johnson-Rabidoux S; Peterson C; Kaufman E; Vickery R Naunyn Schmiedebergs Arch Pharmacol; 2007 May; 375(3):205-20. PubMed ID: 17340127 [TBL] [Abstract][Full Text] [Related]
12. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice. Baker AK; Meert TF J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687 [TBL] [Abstract][Full Text] [Related]
13. Differential effects of agonists on adenylyl cyclase superactivation mediated by the kappa opioid receptors: adenylyl cyclase superactivation is independent of agonist-induced phosphorylation, desensitization, internalization, and down-regulation. Wang Y; Li JG; Huang P; Xu W; Liu-Chen LY J Pharmacol Exp Ther; 2003 Dec; 307(3):1127-34. PubMed ID: 14557376 [TBL] [Abstract][Full Text] [Related]
14. Molecular Interaction Between Butorphanol and κ-Opioid Receptor. Ji J; Lin W; Vrudhula A; Xi J; Yeliseev A; Grothusen JR; Bu W; Liu R Anesth Analg; 2020 Sep; 131(3):935-942. PubMed ID: 32701545 [TBL] [Abstract][Full Text] [Related]
15. Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands. Zhu J; Luo LY; Li JG; Chen C; Liu-Chen LY J Pharmacol Exp Ther; 1997 Aug; 282(2):676-84. PubMed ID: 9262330 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the in vitro efficacy of mu, delta, kappa and ORL1 receptor agonists and non-selective opioid agonists in dog brain membranes. Lester PA; Traynor JR Brain Res; 2006 Feb; 1073-1074():290-6. PubMed ID: 16443205 [TBL] [Abstract][Full Text] [Related]
17. Discriminative stimulus effects of two doses of fentanyl in rats: pharmacological selectivity and effect of training dose on agonist and antagonist effects of mu opioids. Zhang L; Walker EA; Sutherland J; Young AM Psychopharmacology (Berl); 2000 Feb; 148(2):136-45. PubMed ID: 10663428 [TBL] [Abstract][Full Text] [Related]
18. Discriminative stimulus effects of butorphanol: influence of training dose on the substitution patterns produced by Mu, Kappa and Delta opioid agonists. Picker MJ; Benyas S; Horwitz JA; Thompson K; Mathewson C; Smith MA J Pharmacol Exp Ther; 1996 Dec; 279(3):1130-41. PubMed ID: 8968334 [TBL] [Abstract][Full Text] [Related]
19. [The mu, delta and kappa properties of various opioids]. Ohta S; Niwa M; Nozaki M; Hattori M; Shimonaka H; Dohi S Masui; 1995 Sep; 44(9):1228-32. PubMed ID: 8523655 [TBL] [Abstract][Full Text] [Related]
20. Mixed κ/μ partial opioid agonists as potential treatments for cocaine dependence. Bidlack JM Adv Pharmacol; 2014; 69():387-418. PubMed ID: 24484983 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]